SCHEMBL5376318

SCHEMBL5376318

O=C(NN1CCC(Cc2ccccc2)CC1)c1ccc2cc[nH]c2c1Cl

nearest known ligand 0.45

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
HTR2B P41595 1/20 0.45
MAPK14 Q16539 1/20 0.45
FAAH O00519 2/20 0.43
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
MMP2 P08253 1/20 0.41
MMP13 P45452 1/20 0.41
GRIN2D O15399 3/20 0.41
GRIN3B O60391 3/20 0.41
GRIN1 Q05586 3/20 0.41
GRIN2A Q12879 3/20 0.41
GRIN2B Q13224 3/20 0.41
GRIN2C Q14957 3/20 0.41
GRIN3A Q8TCU5 3/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1063927 0.85 CYP2C9 (0.61) CYP2C9CYP2C19HTR2BMAPK14GRIN2D
SCHEMBL5387263 0.82 NR4A2 (0.51) CYP2C9CYP2C19HTR2BMAPK14FAAH
SCHEMBL5374680 0.76 ACHE (0.56) MAPK14GRIN2DGRIN3BGRIN1GRIN2A
SCHEMBL5374496 0.75 TACR1 (0.39)
SCHEMBL7449374 0.74 CCR3 (0.60) FAAHMEN1KMT2A
SCHEMBL9591405 0.70 MEN1 (0.56) FAAHMEN1KMT2A
SCHEMBL1083547 0.68 MAPK14 (0.61) CYP2C9CYP2C19HTR2BMAPK14MEN1
SCHEMBL5373096 0.68 GRIN2B (0.53) MEN1KMT2AGRIN2B
SCHEMBL5376322 0.68 GPR84 (0.51) CYP2C9CYP2C19HTR2BMAPK14MEN1
SCHEMBL1062605 0.67 CYP2C9 (0.63) CYP2C9CYP2C19HTR2BMAPK14MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7189739-B2 Compounds and methods to treat cardiac failure and other disorders SCIOS, INC. (US) 2007-03-13 US disclosed
EP-1080078-B1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC (US) 2006-02-01 EP disclosed
US-6589954-B1 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful SCIOS, INC. 2003-07-08 US disclosed
EP-1080078-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 2001-03-07 EP disclosed
WO-1999061426-A1 HETEROCYCLIC COMPOUNDS AND METHODS TO TREAT CARDIAC FAILURE AND OTHER DISORDERS SCIOS INC. (US) 1999-12-02 WO disclosed